Physician

David W Harden, MD

According to 2025 Medicare claims, David Harden, MD (NPI: 1134184245) practices dermatology in the Manhattan, KS market, with the plurality of this provider's patient population coming from Riley, KS. This provider's primary affiliated billing organization is HEARTLAND DERMATOLOGY AND SKIN CANCER CENTER, PA (NPI: 1538135207; TIN: 481145139) and primary practice location at 66503-7603.

Harden's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,483 traditional Medicare patients, billed 8,775 HCPCS/CPT codes, and received $310,940 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 837 prescription claims across 408 beneficiaries totaling $156,594 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 95 records totaling $1,785. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,258	7,152	$210,828
2016	1,317	7,887	$240,818
2017	1,306	8,035	$249,838
2018	1,354	7,737	$273,062
2019	1,373	8,100	$270,776
2020	1,250	7,017	$246,806
2021	1,339	7,518	$270,432
2022	1,395	7,430	$246,445
2023	1,521	8,294	$292,632
2024	1,483	8,775	$310,940

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	237	631	$72,906
2016	217	572	$68,984
2017	215	613	$73,341
2018	241	636	$63,968
2019	242	677	$50,880
2020	274	680	$25,609
2021	300	720	$69,743
2022	309	747	$78,048
2023	349	827	$83,231
2024	408	837	$156,594

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	390	436	$61
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	200	200	$59
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,073	1,597	$55
17000	Destruction of precancer skin growth, 1 growth	838	1,078	$35
17003	Destruction of precancer skin growth, 2-14 growths	667	3,927	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	61	1,731	$4,429
Betamethasone Dipropionate	Betamethasone Dipropionate	57	1,362	$2,094
Metronidazole	Metronidazole	26	790	$2,028
Doxycycline Hyclate	Doxycycline Hyclate	72	1,536	$1,959
Ketoconazole	Ketoconazole	103	2,721	$1,934

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	95	$1,785	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David W. Harden, MD?

Tedicare shows public-source Medicare data for David W. Harden, MD (NPI 1134184245), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David W. Harden, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David W. Harden, MD?

David W. Harden, MD is linked to HEARTLAND DERMATOLOGY AND SKIN CANCER CENTER, PA (billing NPI 1538135207) in the available physician profile data.

Does David W. Harden, MD have Open Payments data?

David W. Harden, MD has 95 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.